Focus: BioTherapeutics Inc is a Virginia-based biotechnology company founded in 2008 specializing in small molecule therapeutics across immuno-oncology, virology, and translational medicine. The company operates as a mid-cap biotech with active clinical-stage pipeline programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow BioTherapeutics Inc to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Most advanced program in Phase 3; addresses rare metabolic disorder with potential for orphan drug designation and premium pricing.
Help build intelligence for BioTherapeutics Inc
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from BioTherapeutics Inc's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Phase 3 ophthalmology program targeting large-market indication with significant commercial upside if approved.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo